Study title: Intestinal permeability test in systemic lupus erythematosus.Wang SJ, Kao CH, Chen DU, Lan JL.Zhonghua Yi Xue Za Zhi (Taipei). 1992 Jan;49(1):29-33.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Diagnosis | |||||
Brands: Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: CHROMIUM 51 | |||||
ATC code: | |||||
Document link: 2011-09 GE Chromium EDTA response List of published articles.doc | |||||
Document date: 2013-11-08 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |